HomeInvestors HealthRoth starts CG Oncology at buy, cites anticipated FDA filing

Roth starts CG Oncology at buy, cites anticipated FDA filing

525-5250815_gold-ball-free-png-gold-ball-png-clipart

August 28, 2024

Roth starts CG Oncology at buy, cites anticipated FDA filing

Source link

Previous article

Should You Buy Boeing While It’s Below $175?

Next article

Prediction: This Under-the-Radar Tech Stock Will Outperform Nvidia and Apple by 2030

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here